- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 15, 2025 | 20.75M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 15.69M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 6.05M sh |
| Shares Diluted restated | Q3 2025 · Mar 31, 2024 | 267.73K sh |
| Shares Diluted restated | Q3 2025 · Mar 31, 2024 | 204.16K sh |
| Operating Cash Flow | Q3 2025 · Mar 31, 2025 | −$3.12M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | −$3.06M |
| Short Term Debt | Q3 2025 · Mar 31, 2025 | $1.75M |
| Short Term Debt | Q3 2025 · Jun 30, 2024 | $2.25M |
| Short Term Investments | Q3 2025 · Mar 31, 2025 | $44.15K |
| Short Term Investments | Q3 2025 · Jun 30, 2024 | $39.97K |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $192.74K |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $151.88K |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $18.16M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $26M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $48.6M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $27.56M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $59.44M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $47.6M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $34.92M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $20.9M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $85.5M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $84.18M |
| Eps Diluted | Q3 2025 · Mar 31, 2025 | −$0.96 |
| Eps Diluted | Q3 2025 · Mar 31, 2025 | −$3.10 |
| Eps Diluted restated | Q3 2025 · Mar 31, 2024 | −$12.51 |
| Eps Diluted restated | Q3 2025 · Mar 31, 2024 | −$11.32 |
| Eps Basic | Q3 2025 · Mar 31, 2025 | −$0.96 |
| Eps Basic | Q3 2025 · Mar 31, 2025 | −$3.10 |
| Eps Basic restated | Q3 2025 · Mar 31, 2024 | −$12.51 |
| Eps Basic restated | Q3 2025 · Mar 31, 2024 | −$11.32 |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $3.71M |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $5.07M |
| Sga Expense restated | Q3 2025 · Mar 31, 2024 | $1.08M |
| Sga Expense restated | Q3 2025 · Mar 31, 2024 | $7.47M |
| Rd Expense | Q3 2025 · Mar 31, 2025 | $15.49K |
| Rd Expense | Q3 2025 · Mar 31, 2025 | $54.6K |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $31.9K |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $77.81K |
| Net Income | Q3 2025 · Mar 31, 2025 | −$15.12M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$18.77M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$3.35M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$2.31M |
| Operating Income | Q3 2025 · Mar 31, 2025 | −$3.76M |
| Operating Income | Q3 2025 · Mar 31, 2025 | −$5.09M |
| Operating Income restated | Q3 2025 · Mar 31, 2024 | −$1.1M |
| Operating Income restated | Q3 2025 · Mar 31, 2024 | −$7.46M |
| Gross Profit | Q3 2025 · Mar 31, 2025 | −$14.11K |
| Gross Profit | Q3 2025 · Mar 31, 2025 | $122.33K |
| Gross Profit restated | Q3 2025 · Mar 31, 2024 | $71.15K |
| Gross Profit restated | Q3 2025 · Mar 31, 2024 | $246.44K |
| Cost Of Revenue | Q3 2025 · Mar 31, 2025 | $55.08K |
| Cost Of Revenue | Q3 2025 · Mar 31, 2025 | $136.71K |
| Cost Of Revenue restated | Q3 2025 · Mar 31, 2024 | $78.19K |
| Cost Of Revenue restated | Q3 2025 · Mar 31, 2024 | $213.13K |
| Revenue | Q3 2025 · Mar 31, 2025 | $40.97K |
| Revenue | Q3 2025 · Mar 31, 2025 | $259.04K |
| Revenue restated | Q3 2025 · Mar 31, 2024 | $149.35K |
| Revenue restated | Q3 2025 · Mar 31, 2024 | $459.57K |
| Capex restated | Q3 2025 · Mar 31, 2024 | $34.13K |